Focused on innovative cancer therapies, this biotech saw a notable insider sale amid a year of strong share price gains.

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of ...

UroGen Pharma Ltd. (Nasdaq: URGN), a biotechnology company focused on transforming the treatment of urothelial and specialty cancers, today announced that management will present at the Goldman Sachs ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

View UroGen Pharma Ltd. URGN stock quote prices, financial information, real-time forecasts, and company news from CNN.

PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today ...

Transaction value based on SEC Form 4 weighted average purchase price ($27.30); post-transaction value based on the value of post-transaction holdings as reported in the Form 4. UroGen Pharma Ltd.

UroGen Pharma is reaffirmed as a Strong Buy, with a 12-month price target raised to $39/share, reflecting robust Q1 2026 results. Zusduri sales more than doubled QoQ to $29.2M, driven by the January J ...

PRINCETON, N.J., May 06, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and ...

UroGen Pharma (NASDAQ:URGN) is set to give its latest quarterly earnings report on Monday, 2026-03-02. Here's what investors need to know before the announcement. Analysts estimate that UroGen Pharma ...

UroGen Pharma Ltd.(NASDAQ:URGN) shares traded lower Wednesday after the Oncologic Drugs Advisory Committee (ODAC) of the Food and Drug Administration voted against the benefit/risk of UGN-102 ...